AWS
IDXX icon

Atria Wealth Solutions’s Idexx Laboratories IDXX Stock Holding History

Atria Wealth Solutions’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$853K Sell
1,589
-3,459
-69% -$1.65M 0.02% 705
2025
Q1 		$2.12M Buy
5,048
+115
+2% +$49.9K 0.03% 611
2024
Q4 		$2.04M Sell
4,933
-1,229
-20% -$539K 0.02% 633
2024
Q3 		$3.11M Buy
6,162
+397
+7% +$193K 0.03% 485
2024
Q2 		$2.81M Buy
5,765
+120
+2% +$60.2K 0.03% 514
2024
Q1 		$3.05M Buy
5,645
+535
+10% +$292K 0.03% 492
2023
Q4 		$2.84M Sell
5,110
-39
-0.8% -$18.3K 0.04% 486
2023
Q3 		$2.25M Buy
5,149
+15
+0.3% +$7.48K 0.03% 519
2023
Q2 		$2.58M Buy
5,134
+1,376
+37% +$659K 0.04% 485
2023
Q1 		$1.88M Sell
3,758
-76
-2% -$36.4K 0.03% 564
2022
Q4 		$1.56M Buy
3,834
+225
+6% +$87.3K 0.03% 601
2022
Q3 		$1.18M Sell
3,609
-2,305
-39% -$847K 0.02% 663
2022
Q2 		$2.08M Buy
5,914
+3,418
+137% +$1.39M 0.04% 431
2022
Q1 		$1.36M Buy
+2,496
New +$1.31M 0.02% 610

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Atria Wealth Solutions's IDXX Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Idexx Laboratories (IDXX) stake by 69% in Q2 2025, selling an estimated $1.65M and leaving 1,589 shares worth $853K. The position accounts for 0.02% of the portfolio, ranked #705.

Atria Wealth Solutions first reported a position in IDXX in Q1 2022 and has held it in 14 quarters since. The position peaked at $3.11M in Q3 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Atria Wealth Solutions held 1,589 shares of Idexx Laboratories worth $853K as of Q2 2025.
  • Atria Wealth Solutions sold 3,459 Idexx Laboratories shares in Q2 2025, an estimated $1.65M.
  • Idexx Laboratories made up 0.02% of Atria Wealth Solutions's portfolio in Q2 2025, its #705 holding.
  • Atria Wealth Solutions first reported a position in Idexx Laboratories in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Idexx Laboratories position peaked at $3.11M in Q3 2024.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.